trial
as of 2026-07-01Optimisation of Antipsychotic Drug Use in Older People
NCTId NCT01454453
at a glance
Phase 4 · Terminated
Enrollment 64 (actual)
Sponsored by Institute of Psychiatry, London
Primary completion 2015-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Terminated
Enrollment
64 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2012-05
Primary completion
2015-07
Eligibility
ALL · 60 Years · 95 Years
Interventions & indications
Sponsors
Institute of Psychiatry, LondonLead Sponsor
Investigators
1
Suzanne J Reeves, MBChB, PhDPrincipal Investigator
Sites
1 total
London, United Kingdom
Facts & assertions
4 sourced
Enrollment
64
Phase
PHASE4
Primary Completion Date
2015-07
Status
TERMINATED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator